ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB Subcommittee Urges New Centers Categories, Recognition Of More New Comprehensive Centers

March 28, 1975

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users

July 27, 2012

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002

Varmus: Why are scientific societies obstructing public access to research results?

May 20, 2005